A2B395 Produces Early Logic-Gated CAR-T Responses
Early DENALI-1 data from ten adults treated with the allogeneic, EGFR-directed A2B395 Tmod CAR-T product included a Day-28 complete response in one patient with metastatic anal cancer and a confirmed Day-180 partial response in…
